Contents
PB Fintech, the parent company of Policybazaar, witnessed one of its sharpest stock-market falls on September 24, with the share falling more than 30% during the trading session.
It wasn't alone.
Turtlemint fell 20%, Max Financial Services lost around 10–12% during the session, while HDFC Life and ICICI Prudential Life also came under pressure.
The trigger was a major consultation paper released by the Insurance Regulatory and Development Authority of India (IRDAI) a day earlier.
But why should changes in insurance commissions cause such a dramatic reaction in stocks such as Policybazaar?
The answer lies in how insurance is sold in India — and who gets paid for selling it.
Let's simplify it.
Market context: 24 September 2026. Price moves below are intraday observations, not closing prices or a live market feed.
What Has IRDAI Proposed?
IRDAI's consultation paper is called “Recalibrating Economics of Insurance Distribution.”
In simple terms, the regulator wants to reduce the cost involved in selling insurance and change the incentives available to insurance agents, banks, brokers and digital platforms.
The proposals cover five major areas:
- Lower commissions paid for selling several types of insurance.
- Lower overall expense limits for insurance companies.
- Different commission limits depending on how difficult a product is to sell.
- Tighter rules against mis-selling and compulsory insurance bundling.
- Greater use of digital infrastructure such as Bima Sugam and the Public Insurance Registry.
Importantly, these are proposals — not final regulations. IRDAI has invited comments until October 25, 2026, and the framework currently envisages implementation from FY28. Source: IRDAI consultation coverage.
Why Is IRDAI Changing the Rules?
Until 2023, insurance commissions were governed by more product-specific limits.
The framework was subsequently made more flexible, allowing insurance companies greater freedom over commissions as long as overall expenses remained within regulatory limits.
But commissions increased sharply.
IRDAI's analysis suggests that distributor remuneration in several channels grew substantially faster than the insurance premium being generated.
For example, in a sample covering a large portion of life insurance business sourced by corporate agents, new business premium reportedly grew around 28% between FY23 and FY25 while distributor remuneration increased around 125%. Source: Economic Times BFSI.
IRDAI's concern is simple:
If distribution costs keep increasing much faster than insurance premiums, part of that cost ultimately comes out of either the insurer's profitability or the policyholder's returns and premium economics.
The regulator therefore wants remuneration to be more closely linked to the actual effort required to sell and service a policy.
First, Understand "Expense of Management" or EoM
One term investors will hear repeatedly over the next few weeks is EoM — Expense of Management.
Think of it as the amount an insurance company is permitted to spend on running and distributing its business, including expenses associated with sales and commissions.
IRDAI is proposing to reduce these limits progressively.
| Insurer | Proposed limit within 2 years | Proposed limit within 5 years |
|---|---|---|
| Life insurance companies | 15% of GDPI | 12.5% |
| General insurance companies | 25% | 20% |
For general insurers, IRDAI also proposes changing the calculation base from Gross Written Premium to domestic Gross Direct Premium Income. Source: Business Standard.
Why does this matter?
Because insurers may have less money available for customer acquisition and distribution, putting pressure on commissions across the ecosystem.
The Bigger Change: Insurance Commission Caps Are Coming Back
This is probably the most important part of the paper.
IRDAI proposes product-specific and channel-specific commission limits.
A distributor selling multiple insurers' products through an open architecture would generally face lower limits than an individual or tied agent.
The stated logic is that remuneration should reflect the complexity of the product and the effort required to sell it — rather than simply the premium collected.
Some proposed limits illustrate how significant the changes could be:
| Insurance product | Distribution Entity | Individual Agent |
|---|---|---|
| Individual health — new policy | 15% | 20% |
| Health — renewal | 5% | 10% |
| Health — porting | 5% | 10% |
| Motor third-party on new vehicle | Nil | 2.5% |
| Motor own damage on new vehicle | 5% | 10% |
| Pure term life — first year | 25% | 30% |
| Pure term life — renewal | 7.5% | 10% |
The term-life rows refer to individual multi-year pure-term policies. These are proposed ceilings, not rates currently in force. Source: reported product-by-product caps.
For several conventional life products, distributor first-year commissions are proposed in the 5–20% range depending on premium-payment tenure.
That is a major change in distribution economics.
Why Is PB Fintech Particularly Affected?
This brings us to Policybazaar.
PB Fintech is different from an insurance company such as HDFC Life or SBI Life.
Policybazaar primarily acts as a distribution marketplace. It helps customers compare and buy policies from different insurers and earns revenue from the distribution ecosystem.
This makes commission rates and insurance “take rates” much more directly relevant to its economics.
Four parts of IRDAI's proposal are particularly important.
1. Open architecture may receive lower commissions
Policybazaar's value proposition is partly based on offering customers products from multiple insurers.
The consultation paper explicitly proposes lower commission ceilings for open-architecture distributors compared with more restricted individual-agent structures.
That directly affects the economics of comparison-led distribution platforms.
2. Health insurance renewals could become much less lucrative
Health insurance is an increasingly important business for Policybazaar.
PB Fintech reported that new health insurance premium grew 59% year-on-year in Q1 FY27, while its total insurance premium reached ₹8,372 crore. Source: Q1 FY27 results coverage.
Under the draft, health commissions for distribution entities could fall to around 5% for renewals and porting, compared with 15% for first-time policies.
That changes the economics of the valuable recurring customer base built over many years.
3. Motor insurance commissions could decline sharply
Mandatory motor third-party insurance requires relatively little persuasion because the customer is legally required to purchase it.
IRDAI therefore proposes little or no commission on such policies.
Similar reductions are proposed for motor own-damage products.
4. Moving payments outside "commission" may become harder
This is an important but less discussed part of the draft.
IRDAI proposes treating a wide range of monetary and non-monetary benefits as part of commission — including incentives, reimbursement of selling expenses and certain other payments.
In other words, regulators are trying to ensure that commission limits cannot simply be circumvented by renaming compensation as marketing support or another commercial arrangement.
That makes the proposed caps more meaningful.
Why Did PB Fintech Stock Fall So Much?
PB Fintech fell as much as roughly 34% during the September 24 session, wiping out around ₹30,000 crore of market capitalisation at one stage. Source: Moneycontrol, 24 September intraday report.
The market isn't necessarily saying Policybazaar stops growing.
It is questioning how profitable each rupee of future insurance premium could be if distributor commissions fall substantially.
Brokerages were quick to highlight the sensitivity.
Jefferies estimated that a 10% reduction in commission rates could translate into roughly a 10–12% decline in earnings for PB Fintech and Turtlemint. Source: reported Jefferies sensitivity analysis.
Macquarie has separately estimated that a 200-basis-point compression in Policybazaar's take rate could have a much larger effect on EBITDA. These are brokerage scenarios rather than company guidance, but they illustrate why investors reacted so strongly.
Policybazaar also has significant technology, employee, customer-acquisition and support infrastructure.
If the revenue earned from each policy falls while these costs do not fall proportionately, operating leverage can work in reverse.
That is the key concern.
What About HDFC Life, SBI Life, LIC and Other Insurers?
Here the story becomes much more nuanced.
For an insurer, lower commissions are not automatically bad.
A commission paid to a distributor is an expense for the insurance company.
So lower commissions can actually improve insurer margins.
But there is another side.
Agents, banks and digital platforms may have less incentive to aggressively sell a product if they earn substantially less from it.
That could slow premium growth.
Therefore insurers face two opposing forces:
Lower commissions → lower acquisition costs → potentially better margins
versus
Lower commissions → weaker distributor incentives → potentially slower sales growth
Which force dominates will vary significantly by insurer.
Jefferies has modelled scenarios ranging from lower growth and weaker VNB to improved margins if acquisition costs fall without materially damaging sales.
Why SBI Life and LIC May Be Less Affected
Brokerages including Macquarie, Bernstein and HSBC have suggested that SBI Life and LIC could be relatively less exposed than several peers because of their lower-cost distribution structures and greater reliance on agency or captive ecosystems.
HDFC Life, Max Financial and some other private insurers could face greater adjustment depending on their distribution mix and current acquisition costs.
The market itself began reflecting this distinction during the September 24 session.
While HDFC Life and Max Financial remained under pressure, SBI Life was close to flat later in the session, while ICICI Lombard and Go Digit actually traded higher at one stage.
So this is not necessarily a uniformly negative development for all insurance companies.
It is primarily a reset of distribution economics.
Banks and NBFCs Could Also Be Hit
The impact extends well beyond listed insurers.
Banks and NBFCs earn significant fee income by distributing insurance, particularly products sold alongside loans.
IRDAI proposes:
- Commission caps of roughly 2–5% on several loan-linked insurance products.
- A ban on compulsory bundling of insurance with loans.
- Restrictions on volume-linked incentives for employees selling insurance.
For lenders with large credit-protection or bancassurance businesses, this could reduce high-margin fee income.
This explains why several banking and NBFC stocks also came under pressure following the announcement.
What Does IRDAI Mean by Banning Insurance "Dark Patterns"?
Another interesting proposal relates directly to online insurance purchasing.
Imagine visiting an insurance website simply to check the price of a health policy.
Before you can see anything useful, the website asks for your name, mobile number and email address.
Minutes later, sales calls begin.
IRDAI considers practices that unnecessarily force consumers to provide personal information before accessing basic product or pricing information as a potential dark pattern.
The consultation proposes greater transparency and restrictions around such practices.
For consumers, this could eventually mean easier comparison of insurance products without immediately entering a sales funnel.
What Could Change for Insurance Buyers?
If implemented effectively, several changes could ultimately benefit policyholders.
Insurance distribution costs could fall, compulsory insurance bundled with loans could reduce, commission structures could become more transparent, and accountability for mis-selling could improve.
IRDAI also plans to strengthen digital infrastructure through Bima Sugam and a Public Insurance Registry, creating more “pull-based” insurance buying where customers search and compare products instead of relying entirely on aggressive selling.
However, lower commissions do not automatically mean your insurance premium will fall immediately.
Insurers could use the savings in several ways — lower pricing, better policyholder returns, higher margins or additional investment in service and technology.
The eventual impact will depend on competition.
Is the Policybazaar Sell-Off Justified?
That question cannot be answered simply from a consultation paper.
The crucial point is that nothing has changed legally yet.
The document is a draft.
Industry participants can respond until October 25, after which IRDAI may modify the proposed limits or implementation framework.
Strong industry pushback is therefore possible, particularly because insurance remains a distribution-intensive business in India.
What today's market reaction tells us is different:
Investors had been assuming strong premium growth could continue alongside attractive distribution economics.
IRDAI's paper has introduced uncertainty into the second half of that equation.
The Bigger Picture
The most useful way to understand IRDAI's proposal is not:
“Insurance companies are in trouble.”
It is:
“IRDAI wants to reduce the amount of economics captured by distribution and redirect more value towards the policyholder.”
That distinction matters.
Pure distributors such as Policybazaar and Turtlemint face the most direct risk because commissions represent revenue.
Banks and NBFCs could lose lucrative fee income from insurance distribution.
Insurance companies face a mixed outcome: lower acquisition costs could support margins, but weaker distributor incentives could slow growth.
And consumers could ultimately benefit through greater transparency, lower distribution costs and fewer aggressive sales practices.
That is why the same regulation can be strongly negative for one insurance stock, neutral for another and potentially beneficial for a third.
What Investors Should Watch Next
The key developments now are the final commission ceilings after industry consultation, whether the FY28 implementation timeline changes, how insurers renegotiate distribution arrangements, how Policybazaar adapts its customer-acquisition model, and whether lower acquisition costs translate into better margins or simply slower industry growth.
The next few weeks of industry feedback could therefore be as important as the consultation paper itself.
Frequently Asked Questions
Why did PB Fintech share price fall today?
PB Fintech fell sharply after IRDAI proposed significantly lower commission limits across health, life and motor insurance distribution. Because Policybazaar earns a substantial part of its revenue from insurance distribution, investors are concerned that lower take rates could affect its future profitability.
What is the IRDAI consultation paper released in September 2026?
IRDAI released a consultation paper titled “Recalibrating Economics of Insurance Distribution” on September 23, 2026. It proposes changes to insurance commissions, expense limits, distribution structures, mis-selling rules and digital insurance infrastructure.
Are the new IRDAI insurance commission rules final?
No. The proposals are currently part of a consultation paper. IRDAI has invited feedback until October 25, 2026, and the final regulations may differ from the draft.
When could the new insurance commission rules take effect?
The current proposal envisages implementation beginning from FY28, with insurer expense limits declining progressively over several years.
Which companies could be most affected?
Insurance distributors such as PB Fintech and Turtlemint face the most direct impact because commission income is central to their business models. Banks and NBFCs with large insurance-distribution businesses may also be affected. The impact on insurers such as HDFC Life, SBI Life, LIC and ICICI Lombard will depend on their existing costs, product mix and distribution channels.
Will insurance become cheaper?
Possibly, but it is not guaranteed. Lower distribution costs create room for insurers to reduce prices or improve policyholder returns, but the extent to which these savings are passed on will depend on competition and the final regulations.
Disclaimer: This article is for educational and informational purposes only. References to listed companies are intended to explain the potential impact of regulatory developments and should not be construed as investment recommendations. Investors should evaluate company-specific fundamentals, valuations and risks before making investment decisions.